You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023307033
Dec 202313207
Jan 20246502
Feb 20246802
Mar 20246004
Apr 20244002
May 20244405
Jun 20244607
Jul 20243801
Aug 20245202
Sep 20243702
Oct 20245605
Nov 20245005
Dec 20246207
Jan 202580011
Feb 20251304
Apr 2025006
May 2025005
Jun 2025105
Total11510115